IN THIS ISSUE

Researchers from the University of Toronto have published an overview of clinical trial and health data transparency across the Americas. We speak to the report authors to find out more. Plus, we examine the manufacturing challenges associated with gene and cell therapies, and explore how Amazon’s Pillpack acquisition could rattle the industry.

Also, we take a look at the evolving role of biomarkers in cancer drug development, examine the highs and lows of hormone replacement therapy drugs, and find out how Verge Genomics employs proprietary genomic datasets to create some of the field’s largest, comprehensive sources for ALS and Parkinson’s data.

Finally, we explore what life sciences firms can achieve with AI, find out why setting practical parameters can help to provide more accurate regulatory resourcing, and we find out why cannabis branding will be key to grabbing the attention of consumers in fledgling markets.

Eloise McLennan, editor

Go to article: Home | Maximising ManufacturingGo to article: EditorialGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: MedelpharmGo to article: NewsGo to article: B & W Tek Go to article: The Pharma Industry BriefingGo to article: Clinical trial transparency in the Americas Go to article: Malvern Panalytical Company InsightGo to article: Malvern PanalyticalGo to article: AralabGo to article: Gene and cell therapies: making manufacturing workGo to article: Capsugel Company InsightGo to article: Abiogen PharmaGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: GerresheimerGo to article: SGSGo to article: Cancer trials: making the most of biomarkersGo to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: The highs and lows of hormone replacement therapyGo to article: EcocoolGo to article: LaudaGo to article: Verge Genomics: employing AI to improve drug discoveryGo to article: AirBridgeCargo Company InsightGo to article: AirBridgeCargoGo to article: Senn ChemicalsGo to article: What can life sciences firms really achieve with AI?Go to article: Pall BiotechGo to article: CBDepotGo to article: G.F.Go to article: Setting practical parameters for more accurate regulatory resourcingGo to article: TSS ABGo to article: MasterpackGo to article: HOF SonderanlagenbauGo to article: Röchling Medical NeuhausGo to article: Cannabis branding: Marketing an industry from the ground upGo to article: AlpexGo to article: PharmasolGo to article: EventsGo to article: AECO Telecom & Security SystemsGo to article: Event: CPhI WorldwideGo to article: HTI PlasticsGo to article: SanofiGo to article: Event: Outsourcing in Clinical Trials DACH 2018Go to article: Procaps Company InsightGo to article: ProcapsGo to article: Event: Big Data & Analytics for Pharma Summit Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Next issueGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ILC Dover IncGo to article: Scilabware